Mesoblast Limited (OTCMKTS:MEOBF – Get Free Report) passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.45 and traded as high as $0.71. Mesoblast shares last traded at $0.71, with a volume of 202 shares changing hands.
Mesoblast Price Performance
The company’s fifty day moving average is $0.75 and its 200 day moving average is $0.46.
Mesoblast Company Profile
Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells.
Featured Stories
- Five stocks we like better than Mesoblast
- When to Sell a Stock for Profit or Loss
- Top 3 Beverage Stocks: Summer Earnings Reveal Key Trends
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- This Financial Stock’s Earnings Signal a Buying Opportunity
- How to Invest in Biotech Stocks
- Social Platform Stock Hits New Highs: Is More Growth Ahead?
Receive News & Ratings for Mesoblast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast and related companies with MarketBeat.com's FREE daily email newsletter.